AVE avecho biotechnology limited

The upcoming interimanalysis represents a key inflection point...

  1. 5,231 Posts.
    lightbulb Created with Sketch. 9686
    The upcoming interim
    analysis represents a key inflection point in our development program, which has already opened up
    substantial opportunities for partnership discussions and licensing agreements both locally and
    globally.”

    'opened up substantial opportunities' is interesting phrasing - think this is more than a 'claytons' opportunity

    just my opinion
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $12.69M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $19.74K 4.935M

Buyers (Bids)

No. Vol. Price($)
6 3510852 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 32271696 26
View Market Depth
Last trade - 15.15pm 26/06/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.